Volume 28; Issue supp-S16

Main
Seminars in Oncology
Volume 28; Issue supp-S16

Seminars in Oncology

Volume 28; Issue supp-S16

1

Introduction

Gabriel N Hortobagyi

Journal:

Seminars in Oncology

Year:

2001

Language:

english

File:

PDF, 338 KB

english, 2001

2

Mechanism of action of trastuzumab and scientific update

José Baselga, Joan Albanell, Miguel Angel Molina, Joaquin Arribas

Journal:

Seminars in Oncology

Year:

2001

Language:

english

File:

PDF, 3.92 MB

english, 2001

3

Mechanisms of ErbB2-mediated paclitaxel resistance and trastuzumab-mediated paclitaxel sensitization in ErbB2-overexpressing breast cancers

Journal:

Seminars in Oncology

Year:

2001

Language:

english

File:

PDF, 804 KB

english, 2001

4

Cardiotoxicity in signal transduction therapeutics: ErbB2 antibodies and the heart

Jay W Schneider, Alice Y Chang, Thomas P Rocco

Journal:

Seminars in Oncology

Year:

2001

Language:

english

File:

PDF, 2.00 MB

english, 2001

5

The role of HER2 in angiogenesis

Rakesh Kumar, Rozita Yarmand-Bagheri

Journal:

Seminars in Oncology

Year:

2001

Language:

english

File:

PDF, 1.76 MB

english, 2001

6

Optimal duration of therapy with trastuzumab

Gabriel N Hortobagyi

Journal:

Seminars in Oncology

Year:

2001

Language:

english

File:

PDF, 907 KB

english, 2001

7

Integration of trastuzumab into adjuvant systemic therapy of breast cancer: Ongoing and planned clinical trials

Gabriel N Hortobagyi, Edith A Perez

Journal:

Seminars in Oncology

Year:

2001

Language:

english

File:

PDF, 684 KB

english, 2001

8

Tyrosine kinase inhibitors: Rationale, mechanisms of action, and implications for drug resistance

Dagmar Busse, F.Michael Yakes, Anne E.G Lenferink, Carlos L Arteaga

Journal:

Seminars in Oncology

Year:

2001

Language:

english

File:

PDF, 1.06 MB

english, 2001

9

Pharmacodynamic studies with the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839

Joan Albanell, Federico Rojo, José Baselga

Journal:

Seminars in Oncology

Year:

2001

Language:

english

File:

PDF, 5.42 MB

english, 2001

10

Anticancer therapy targeting the erbB family of receptor tyrosine kinases

William J Slichenmyer, David W Fry

Journal:

Seminars in Oncology

Year:

2001

Language:

english

File:

PDF, 1.90 MB

english, 2001

11

CI-1033, a pan-erbB tyrosine kinase inhibitor

William J Slichenmyer, William L Elliott, David W Fry

Journal:

Seminars in Oncology

Year:

2001

Language:

english

File:

PDF, 1.14 MB

english, 2001

12

Farnesyltransferase inhibitors

Stephen M Hahn, Eric Bernhard, W.Gillies McKenna

Journal:

Seminars in Oncology

Year:

2001

Language:

english

File:

PDF, 856 KB

english, 2001

13

Overview of angiogenesis: Biologic implications for antiangiogenic therapy

Lee M Ellis, Wenbiao Liu, Syed A Ahmad, Fan Fan, Young Do Jung, Raymond M Shaheen, Niels Reinmuth

Journal:

Seminars in Oncology

Year:

2001

Language:

english

File:

PDF, 6.10 MB

english, 2001

14

Clinical evaluation of adenoviral-mediated p53 gene transfer: Review of INGN 201 studies

James A Merritt, Jack A Roth, Christopher J Logothetis

Journal:

Seminars in Oncology

Year:

2001

Language:

english

File:

PDF, 1.08 MB

english, 2001

15

HER2 overexpression and cancer targeting

Shao-Chun Wang, Mien-Chie Hung

Journal:

Seminars in Oncology

Year:

2001

Language:

english

File:

PDF, 1.15 MB

english, 2001

16

The role of genetic abnormalities of PTEN and the phosphatidylinositol 3-kinase pathway in breast and ovarian tumorigenesis, prognosis, and therapy

Gordon B Mills, Yiling Lu, Xianjun Fang, Hongwei Wang, Astrid Eder, Muling Mao, Ramona Swaby, Kwai Wa Cheng, David Stokoe, Kathy Siminovitch, Robert Jaffe, Joe Gray

Journal:

Seminars in Oncology

Year:

2001

Language:

english

File:

PDF, 1.91 MB

english, 2001

17

GRB2: A pivotal protein in signal transduction

Ana M Tari, Gabriel Lopez-Berestein

Journal:

Seminars in Oncology

Year:

2001

Language:

english

File:

PDF, 664 KB

english, 2001

18

Novel agents: Clinical trial design

Antoinette R Tan, Sandra M Swain

Journal:

Seminars in Oncology

Year:

2001

Language:

english

File:

PDF, 667 KB

english, 2001

19

CME questions

Journal:

Seminars in Oncology

Year:

2001

Language:

english

File:

PDF, 634 KB

english, 2001

20

Targeted therapies in the treatment of breast cancer: Faculty disclosure

Journal:

Seminars in Oncology

Year:

2001

Language:

english

File:

PDF, 75 KB

english, 2001

21

Targeted therapies in the treatment of breast cancer: Unlabeled uses of commercial products or investigational uses not yet approved

Journal:

Seminars in Oncology

Year:

2001

Language:

english

File:

PDF, 65 KB

english, 2001